Infant RSV Vaccine Study

Now Enrolling in Omaha and Norfolk

Now Enrolling

About this research study

More than a common cold, RSV can lead to severe infections, including pneumonia. In the U.S., RSV is the leading cause of infant hospitalization. Scientists are researching an investigational vaccine.

Eligible participants...

  • Must be 6 months to 2 years
  • Must have been born at full term of pregnancy
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Omaha, Nebraska • Velocity Clinical Research

3319 N. 107th St., Omaha, NE 68134
Phone: (513) 381-3320

Norfolk, Nebraska • Velocity Clinical Research

3400 W Norfolk Avenue, Norfolk, NE 68701
Phone: (402) 371-0797
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy